Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline—A population-based cohort study

International Journal of Cancer

Volumn 140, Issue 8, 2017, Pages 1850-1859

  Mittal, Srabani ^a   Basu, Partha ^b   Muwonge, Richard ^b   Banerjee, Dipanwita ^a   Ghosh, Ishita ^a   Sengupta, Mitali Mukherjee ^a   Das, Pradip ^a   Dey, Priatosh ^a   Mandal, Ranajit ^a   Panda, Chinmay ^a   Biswas, Jaydip ^a   Sankaranarayanan, Rengaswamy ^b  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

cervical intraepithelial neoplasia; cumulative risk; high risk human papillomavirus; hybrid capture II; viral load

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; POPULATION RESEARCH; PRECANCER; TUMOR INVASION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD; CERVICAL INTRAEPITHELIAL NEOPLASIA; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOGENICITY; PATHOLOGY; PREGNANCY; RISK FACTOR; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; RISK FACTORS; VAGINAL SMEARS; VIRAL LOAD;

EID: 85013080853     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30609     Document Type: Article

References (29)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–19.
2. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244–65
3. Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003;31:14–9
4. Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186–92.
5. Bansal N, Wright JD, Cohen CJ, et al. Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Res 2008;28:1763–6.
6. Thulaseedharan JV, Malila N, Esmy PO, et al. Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural South India. Int J Gynaecol Obstet 2015;129:104–8.
7. Mittal S, Mandal R, Banerjee D, et al. HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India. Cancer Causes Control 2016;27:351–8.
8. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106–14.
9. Dalstein V, Riethmuller D, Prétet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 2003;106:396–403.
10. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365–71.
11. Kjaer S, Hogdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 2006;66:10630–6.
12. Castle PE, Schiffman M, Herrero R, et al. Prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191:1808–16.
13. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072–9.
14. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235–40.
15. Muñoz N, Méndez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077–87.
16. Rodríguez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010;102:315–24.
17. Wright TC. Natural history of HPV infections. J Fam Pract 2009;58:S3–7.
18. Gravitt PE, Burk RD, Lorincz A, et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 2003;12:477–84.
19. Basu P, Muwonge R, Mittal S, et al. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2in colposcopy practice. J Med Screen 2016;23:104–10.
20. Origoni M, Carminati G, Rolla S, et al. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis 2012;31:2401–6.
21. Origoni M, Carminati G, Sideri M, et al. Low-grade positivity of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3. Eur J Gynaecol Oncol 2012;33:261–4.
22. Sun CA, Lai HC, Chang CC, et al. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001;83:95–9.
23. Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2189–93.
24. Depuydt CE, Jonckheere J, Berth M, et al. Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections. Cancer Med 2015;4:1294–302.
25. Clavel C, Masure M, Levert M, et al. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol 2000;9:145–50.
26. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360:228–9.
27. Mittal S, Ghosh I, Banerjee D, et al. Reproducibility of cervical intraepithelial neoplasia diagnosis on histological review of cervical punch biopsies from a visual inspection with acetic acid and HPV detection-based screening program. Int J Gynaecol Obstet 2014;126:227–31.
28. Cox JT, Schiffman M, Solomon D, ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406–12.
29. Basu P, Sarkar S, Mukherjee S, et al. Women's perceptions and social barriers determine compliance to cervical screening: results from a population based study in India. Cancer Detect Prev 2006;30:369–74.